its healthcare-specific offerings to retain business, and Blackstone's acquisition can help expand into international markets: Ancestry's CEO stated that the collaboration with Blackstone will help "expand [its] Global Family History Business" and "vision of preventative health."
While the purchase can help Ancestry grow — it could heighten consumers' distrust and make them even less willing to share their data with the genetic testing firm. Many consumers have been hesitant about sharing their DNA with genetic testing firms: We think Ancestry's deal with Blackstone could amplify these privacy concerns, considering it will now be owned by a private investment firm — not a company with expertise in genomics.
We think privacy concerns could also make health systems wary about potential tie-ups, stymieing Ancestry's efforts to wade deeper into healthcare. Ancestry has made major strides to dive deeper into the healthcare realm: Earlier this week, it its next generation sequencing product, which will examine difficult-to-sequence variants of the human genome to screen users for genes associated with diseases like breast cancer.
While the purchase can help Ancestry grow — it could heighten consumers' distrust and make them even less willing to share their data with the genetic testing firm profitgrowth business
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
ソース: BusinessInsider - 🏆 729. / 51 続きを読む »
ソース: BusinessInsider - 🏆 729. / 51 続きを読む »
ソース: BusinessInsider - 🏆 729. / 51 続きを読む »